BFC Planning’s Impact BioMedical IBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$95 Hold
17
– – ﹤0.01% 3391
2026
Q2
$100 Hold
17
– – ﹤0.01% 3351
2026
Q1
$131 Hold
17
– – ﹤0.01% 2952
2025
Q4
$110 Hold
17
– – ﹤0.01% 3079
2025
Q3
$145 Buy
+17
New +$135 ﹤0.01% 2836

Other funds holding IBO

BFC Planning's IBO Position: Q3 2026 in Review

BFC Planning held its Impact BioMedical (IBO) position steady in Q3 2026 at 17 shares worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #3391.

BFC Planning first reported a position in IBO in Q3 2025 and has held it in 5 quarters since. The position peaked at $145 in Q3 2025. 16 funds tracked by Wall St. Rank hold IBO as of Q3 2026.

  • BFC Planning held 17 shares of Impact BioMedical worth $95 as of Q3 2026.
  • BFC Planning left its Impact BioMedical share count unchanged in Q3 2026.
  • Impact BioMedical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3391 holding.
  • BFC Planning first reported a position in Impact BioMedical in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Impact BioMedical position peaked at $145 in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.